Detalles de la búsqueda
1.
Cost-effectiveness analysis of cytomegalovirus prophylaxis in allogeneic hematopoietic cell transplant recipients from a US payer perspective.
J Med Virol
; 93(6): 3786-3794, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32844453
2.
Real-world cost-effectiveness of etonogestrel implants compared to long-term and short term reversible contraceptive methods in France.
Eur J Contracept Reprod Health Care
; 26(4): 303-311, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33960248
3.
Deep learning system for true- and pseudo-invasion in colorectal polyps.
Sci Rep
; 14(1): 426, 2024 01 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38172166
4.
The Growing Economic and Clinical Burden of Nonalcoholic Steatohepatitis (NASH) in the United States.
J Clin Exp Hepatol
; 13(3): 454-467, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37250870
5.
Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms.
Infect Dis Ther
; 11(4): 1443-1457, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35334080
6.
Cost Effectiveness of Ceftolozane/Tazobactam Compared with Meropenem for the Treatment of Patients with Ventilated Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia.
Infect Dis Ther
; 10(2): 939-954, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33837518
7.
Healthcare Resource Utilization of Ceftolozane/Tazobactam Versus Meropenem for Ventilated Nosocomial Pneumonia from the Randomized, Controlled, Double-Blind ASPECT-NP Trial.
Infect Dis Ther
; 9(4): 953-966, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32996064
8.
Costo-efficacia di IMI/CIL/REL rispetto a CMS+IMI per il trattamento di infezioni batteriche Gram-negative non sensibili ai carbapenemi.
Glob Reg Health Technol Assess
; 10: 18-28, 2023.
Artículo
en Italiano
| MEDLINE | ID: mdl-37070067
9.
Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms.
Infect Dis Ther
; 11(4): 1459-1460, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35749011
Resultados
1 -
9
de 9
1
Próxima >
>>